文摘
Pathway selective ligands of the estrogen receptor inhibittranscriptional activation of proinflammatory genes mediated by NF-B. Substituted 2-cyanopropanoic acid derivatives were developedleading to the discovery of WAY-204688, an orally active, pathwayselective, estrogen receptor dependent anti-inflammatory agent. Thispropanamide was shown to be orally active in preclinical models ofinflammatory diseases, such as rheumatoid arthritis, without theproliferative effect associated with traditional estrogens.